PER 3.37% 8.6¢ percheron therapeutics limited

investor pres announcement. , page-7

  1. 4,149 Posts.
    Multiple program 'shots on goal' with key value inflection points imminent.
    Just means, should these 3 trial results coming up be successful, they will add value to the company.
    Was looking for an update like yourself Zoomy on timelines but they gave nothing away.
    Still think Scm trial will be first out of the box followed by 1102 then 1103. Pretty exciting little period coming up really.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.